Cargando…
Symptoms and impacts of ambulatory nonsense mutation Duchenne muscular dystrophy: a qualitative study and the development of a patient-centred conceptual model
BACKGROUND: Duchenne muscular dystrophy is a rare genetic neuromuscular disorder, which can result in early death due to disease progression. Ataluren is indicated for the treatment of nonsense mutation Duchenne muscular dystrophy, in ambulatory individuals aged two years and older. This study explo...
Autores principales: | Williams, Kate, Davidson, Ian, Rance, Mark, Boehnke, Axel, Buesch, Katharina, Acaster, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380095/ https://www.ncbi.nlm.nih.gov/pubmed/34420127 http://dx.doi.org/10.1186/s41687-021-00341-x |
Ejemplares similares
-
A qualitative study on the impact of caring for an ambulatory individual with nonsense mutation Duchenne muscular dystrophy
por: Williams, Kate, et al.
Publicado: (2021) -
Cost of Illness in Patients with Duchenne Muscular Dystrophy in Portugal: The COIDUCH Study
por: Labisa, Pedro, et al.
Publicado: (2021) -
Prognostic indicators of disease progression in Duchenne muscular dystrophy: A literature review and evidence synthesis
por: Ferizovic, Nermina, et al.
Publicado: (2022) -
Eteplirsen Treatment Attenuates Respiratory Decline in Ambulatory and Non-Ambulatory Patients with Duchenne Muscular Dystrophy
por: Khan, Navid, et al.
Publicado: (2019) -
Ataluren delays loss of ambulation and respiratory decline in nonsense mutation Duchenne muscular dystrophy patients
por: McDonald, Craig M, et al.
Publicado: (2021)